Another interesting company to diligence is Dyne Therapeutics (DYN). Their shares were hit pretty hard this week, apparently because they changed primary outcomes for their upcoming DMD readout. Did the market over-react to that, and in the wrong direction? That is something to dig deeper into.

$XBI $93.75 | +3.31% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

$XBI $93.75 | +3.31% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

(Posted 10:30am CST) $XBI $92.44 | +1.86% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 10:30am CST) $XBI $92.44 | +1.86% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 9:55am CST) $XBI $79.73 | -1.19% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 9:55am CST) $XBI $79.73 | -1.19% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...

$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...